{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T02:28:45Z","timestamp":1768530525341,"version":"3.49.0"},"reference-count":67,"publisher":"The Endocrine Society","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1999,3,1]]},"DOI":"10.1210\/mend.13.3.0255","type":"journal-article","created":{"date-parts":[[2014,1,8]],"date-time":"2014-01-08T17:30:28Z","timestamp":1389202228000},"page":"440-454","source":"Crossref","is-referenced-by-count":141,"title":["Distinguishing Androgen Receptor Agonists and Antagonists: Distinct Mechanisms of Activation by Medroxyprogesterone Acetate and Dihydrotestosterone"],"prefix":"10.1210","volume":"13","author":[{"given":"Jon A.","family":"Kemppainen","sequence":"first","affiliation":[{"name":"Laboratories for Reproductive Biology and the Departments of Pediatrics (J.A.K., E.L., C-i.W., E.M.W.), University of North Carolina Chapel Hill North Carolina 27599"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Langley","sequence":"additional","affiliation":[{"name":"Laboratories for Reproductive Biology and the Departments of Pediatrics (J.A.K., E.L., C-i.W., E.M.W.), University of North Carolina Chapel Hill North Carolina 27599"},{"name":"Biochemistry and Biophysics (E.L., E.M.W.) University of North Carolina Chapel Hill North Carolina 27599"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Choi-iok","family":"Wong","sequence":"additional","affiliation":[{"name":"Laboratories for Reproductive Biology and the Departments of Pediatrics (J.A.K., E.L., C-i.W., E.M.W.), University of North Carolina Chapel Hill North Carolina 27599"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathy","family":"Bobseine","sequence":"additional","affiliation":[{"name":"Endocrinology Branch (K.B., W.R.K.) Reproductive Toxicology Division National Health and Environmental Effects Research Laboratory United States Environmental Protection Agency Research Triangle Park, North Carolina 27711"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William R.","family":"Kelce","sequence":"additional","affiliation":[{"name":"Endocrinology Branch (K.B., W.R.K.) Reproductive Toxicology Division National Health and Environmental Effects Research Laboratory United States Environmental Protection Agency Research Triangle Park, North Carolina 27711"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth M.","family":"Wilson","sequence":"additional","affiliation":[{"name":"Laboratories for Reproductive Biology and the Departments of Pediatrics (J.A.K., E.L., C-i.W., E.M.W.), University of North Carolina Chapel Hill North Carolina 27599"},{"name":"Biochemistry and Biophysics (E.L., E.M.W.) University of North Carolina Chapel Hill North Carolina 27599"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","reference":[{"key":"2019041122545127300_R1","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/375581a0","article-title":"Persistent DDT metabolite p,p\u2032-DDE is a potent androgen receptor antagonist.","volume":"375","author":"Kelce","year":"1995","journal-title":"Nature"},{"key":"2019041122545127300_R2","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/s001090050104","article-title":"Environmental antiandrogens: developmental effects, molecular mechanisms and clinical implications.","volume":"75","author":"Kelce","year":"1997","journal-title":"J Mol Med"},{"key":"2019041122545127300_R3","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1056\/NEJM199101243240406","article-title":"Carcinoma of the prostate.","volume":"324","author":"Gittes","year":"1991","journal-title":"N Engl J Med"},{"key":"2019041122545127300_R4","doi-asserted-by":"crossref","first-page":"29983","DOI":"10.1074\/jbc.270.50.29983","article-title":"Evidence for an anti-parallel orientation of the ligand-activated human androgen receptor dimer.","volume":"270","author":"Langley","year":"1995","journal-title":"J Biol Chem"},{"key":"2019041122545127300_R5","doi-asserted-by":"crossref","first-page":"12314","DOI":"10.1073\/pnas.92.26.12314","article-title":"Ligand-dependent, transcriptionally productive association of the amino- and carboxyl-terminal regions of a steroid hormone nuclear receptor.","volume":"92","author":"Kraus","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041122545127300_R6","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1074\/jbc.273.1.92","article-title":"Intermolecular NH2-\/carboxyl-terminal interactions in androgen receptor dimerization revealed by mutations that cause androgen insensitivity.","volume":"273","author":"Langley","year":"1998","journal-title":"J Biol Chem"},{"key":"2019041122545127300_R7","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/0022-4731(79)90208-5","article-title":"Specific binding of[ 3H]-methyltrienolone to both progestin and androgen binding components in human benign prostatic hypertrophy (BPH).","volume":"10","author":"Asselin","year":"1979","journal-title":"J Steroid Biochem"},{"key":"2019041122545127300_R8","first-page":"169","article-title":"Receptor binding as a tool in the development of new bioactive steroids. In: Ariens EJ (ed) Drug Design.","volume":"8","author":"Raynaud","year":"1979","journal-title":"Academic Press, New York, vol"},{"key":"2019041122545127300_R9","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1210\/endo-104-4-1007","article-title":"Androgen receptor assay with 3H-methyltrienolone (R1881) in the presence of progesterone receptors.","volume":"104","author":"Zava","year":"1979","journal-title":"Endocrinology"},{"key":"2019041122545127300_R10","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0022-4731(85)90270-5","article-title":"Use of a new radioactive ligand, 7\u03b1,17\u03b1-dimethyl[ 17\u03b1-methyl[3H]19-nortestosterone for the estimation of androgen receptor in rat liver cytosol.","volume":"23","author":"Bannister","year":"1985","journal-title":"J Steroid Biochem"},{"key":"2019041122545127300_R11","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/0163-7258(83)90023-2","article-title":"Progestins can mimic, inhibit and potentiate the actions of androgens.","volume":"23","author":"Bardin","year":"1984","journal-title":"Pharmacol Ther"},{"key":"2019041122545127300_R12","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1210\/endo-95-6-1589","article-title":"Synandrogenic and antiandrogenic effect of progestins: comparison with nonprogestational antiandrogens.","volume":"95","author":"Mowszowicz","year":"1974","journal-title":"Endocrinology"},{"key":"2019041122545127300_R13","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0022-4731(80)90264-2","article-title":"Steroid hormone receptors and pharmacology.","volume":"12","author":"Raynaud","year":"1980","journal-title":"J Steroid Biochem"},{"key":"2019041122545127300_R14","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0960-0760(94)90257-7","article-title":"Non-steroidal antiandrogens: synthesis and biological profile of high-affinity ligands for the androgen receptor.","volume":"48","author":"Teutsch","year":"1994","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2019041122545127300_R15","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0960-0760(94)90250-X","article-title":"RU 58841, a new specific topical antiandrogen: a candidate of choice for the treatment of acne, androgenic alopecia and hirsutism.","volume":"48","author":"Battmann","year":"1994","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2019041122545127300_R16","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0090-4295(96)00117-3","article-title":"Agonist and antagonist activities of hydroxyflutamide and casodex relate to androgen receptor stabilization.","volume":"48","author":"Kemppainen","year":"1996","journal-title":"Urology"},{"key":"2019041122545127300_R17","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1126\/science.3201230","article-title":"Many transcription factors interact synergistically with steroid receptors.","volume":"242","author":"Schule","year":"1988","journal-title":"Science"},{"key":"2019041122545127300_R18","first-page":"454","article-title":"Luciferase reporter gene vectors for analysis of promoters and enhancers.","volume":"6","author":"Nordeen","year":"1988","journal-title":"Biotechniques"},{"key":"2019041122545127300_R19","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0303-7207(90)90190-J","article-title":"Synthetic progestins stimulate prostatic binding protein messenger RNAs in the rat ventral prostate.","volume":"68","author":"Labrie","year":"1990","journal-title":"Mol Cell Endocrinol"},{"key":"2019041122545127300_R20","first-page":"513","article-title":"Characterization of mutant androgen receptors causing partial androgen insensitivity syndrome.","volume":"78","author":"Bellis","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122545127300_R21","doi-asserted-by":"crossref","first-page":"8893","DOI":"10.1016\/S0021-9258(19)38972-0","article-title":"A single base mutation in the androgen receptor gene causes androgen insensitivity in the Tfm rat.","volume":"265","author":"Yarbrough","year":"1990","journal-title":"J Biol Chem"},{"key":"2019041122545127300_R22","first-page":"208","article-title":"Specificity of ligand dependent androgen receptor stabilization: receptor domain interactions influence ligand dissociation and receptor stability.","volume":"9","author":"Zhou","year":"1995","journal-title":"Mol Endocrinol"},{"key":"2019041122545127300_R23"},{"key":"2019041122545127300_R24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0960-0760(95)00088-H","article-title":"Steroid hormone receptor status defines the MMTV promoter chromatin structure in vivo.","volume":"53","author":"Archer","year":"1995","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2019041122545127300_R25","doi-asserted-by":"crossref","first-page":"19004","DOI":"10.1016\/S0021-9258(17)46727-5","article-title":"Steroid requirement for androgen receptor dimerization and DNA binding: modulation by intramolecular interactions between the NH2-terminal and steroid binding domains.","volume":"268","author":"Wong","year":"1993","journal-title":"J Biol Chem"},{"key":"2019041122545127300_R26","doi-asserted-by":"crossref","first-page":"19998","DOI":"10.1074\/jbc.270.34.19998","article-title":"Androgen receptor antagonist versus agonist activities of the fungicide vinclozolin relative to hydroxyflutamide.","volume":"270","author":"Wong","year":"1995","journal-title":"J Biol Chem"},{"key":"2019041122545127300_R27","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/S0021-9258(18)48380-9","article-title":"Androgen receptor phosphorylation, turnover, nuclear transport and transcriptional activation: specificity for steroids and antihormones.","volume":"267","author":"Kemppainen","year":"1992","journal-title":"J Biol Chem"},{"key":"2019041122545127300_R28","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/0022-4731(83)90350-3","article-title":"Interaction of medroxyprogesterone acetate with cytosol androgen receptors in the rat hypothalamus and pituitary.","volume":"19","author":"Pe\u0301rez-Palacios","year":"1983","journal-title":"J Steroid Biochem"},{"key":"2019041122545127300_R29","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1210\/endo-103-5-1768","article-title":"Androgenic, antiandrogenic, and synandrogenic actions of progestins: role of steric and allosteric interactions with androgen receptors.","volume":"103","author":"Bullock","year":"1978","journal-title":"Endocrinology"},{"key":"2019041122545127300_R30","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/978-1-4757-6589-2_14","article-title":"In vivo metabolism and binding of 6\u03b1-methylprogesterone: a progestin with anti-androgenic and synandrogenic activities.","author":"Brown","year":"1979","journal-title":"Steroid Hormone Receptor Systems."},{"key":"2019041122545127300_R31","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0022-4731(79)90281-4","article-title":"Action of a non-steroidal antiandrogen, RU 23908, in peripheral and central tissues.","volume":"11","author":"Raynaud","year":"1979","journal-title":"J Steroid Biochem"},{"key":"2019041122545127300_R32","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/0022-4731(78)90050-X","article-title":"Steroid structure and function. II. Conformational transmission and receptor binding of medroxyprogesterone acetate.","volume":"9","author":"Duax","year":"1978","journal-title":"J Steroid Biochem"},{"key":"2019041122545127300_R33","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0022-4731(87)90317-7","article-title":"Towards the mapping of the progesterone and androgen receptors.","volume":"27","author":"Ojasoo","year":"1987","journal-title":"J Steroid Biochem"},{"key":"2019041122545127300_R34","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/0039-128X(74)90063-4","article-title":"Affinities of progestogen and estrogen receptors in rabbit uterus for synthetic progestins.","volume":"23","author":"Terenius","year":"1974","journal-title":"Steroids"},{"key":"2019041122545127300_R35","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/S0022-3476(71)80191-9","article-title":"Adverse effects of large doses of medroxyprogesterone (MPA) in idiopathic isosexual precocity.","volume":"79","author":"Richman","year":"1971","journal-title":"J Pediatr"},{"key":"2019041122545127300_R36","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1016\/S0140-6736(82)91314-9","article-title":"Medroxyprogesterone in in vitro fertilization.","volume":"2","author":"Barlow","year":"1982","journal-title":"Lancet"},{"key":"2019041122545127300_R37","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S0015-0282(16)46823-8","article-title":"Teratogenic effects of Silastic intrauterine devices in the rat with or without added medroxyprogesterone acetate.","volume":"39","author":"Barlow","year":"1983","journal-title":"Fertil Steril"},{"key":"2019041122545127300_R38","first-page":"237","article-title":"Gonadal hormones and the perinatal development of neuroendocrine function.","author":"Gorski","year":"1971","journal-title":"Frontiers in Neuroendocrinology."},{"key":"2019041122545127300_R39","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/tera.1420220302","article-title":"Congenital abnormalities and hormones during pregnancy: a clinical review.","volume":"22","author":"Schardein","year":"1980","journal-title":"Teratology"},{"key":"2019041122545127300_R40","first-page":"2557","article-title":"Estrogen, androgen, glucocorticoid, and progesterone receptors in progestin-induced regression of human breast cancer.","volume":"40","author":"Teulings","year":"1980","journal-title":"Cancer Res"},{"key":"2019041122545127300_R41","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/0002-9378(80)90911-4","article-title":"Binding of medroxyprogesterone acetate in human breast cancer.","volume":"137","author":"Young","year":"1980","journal-title":"Am J Obstet Gynecol"},{"key":"2019041122545127300_R42","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/BF00689836","article-title":"Medroxyprogesterone acetate inhibits the proliferation of estrogen and progesterone receptor negative MFM-223 human mammary cancer cells via the androgen receptor.","volume":"25","author":"Hackenberg","year":"1993","journal-title":"Breast Cancer Res Treat"},{"key":"2019041122545127300_R43","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1200\/JCO.1995.13.7.1572","article-title":"Medroxyprogesterone acetate therapy in advanced breast cancer: the predictive value of androgen receptor expression.","volume":"13","author":"Birrell","year":"1995","journal-title":"J Clin Oncol"},{"key":"2019041122545127300_R44","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1210\/endo.132.1.8380373","article-title":"Androgen receptor mediated stimulation of 17\u03b2-hydroxysteroid dehydrogenase activity by dihydrotestosterone and medroxyprogesterone acetate in ZR-75\u20131 human breast cancer cells.","volume":"132","author":"Couture","year":"1993","journal-title":"Endocrinology"},{"key":"2019041122545127300_R45","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/S0090-9556(25)06830-8","article-title":"Induction of male specific cytochrome P450 isozymes in female rats by oxandrolone.","volume":"23","author":"Waskiewicz","year":"1995","journal-title":"Drug Metab Dispos"},{"key":"2019041122545127300_R46","first-page":"696","article-title":"Reviews of trimetrexate and oxandrolone.","volume":"29","author":"Levien","year":"1994","journal-title":"Hosp Pharm"},{"key":"2019041122545127300_R47","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1136\/adc.60.4.379","article-title":"Oxandrolone in low dose for constitutional delay of growth and puberty in boys.","volume":"60","author":"Stanhope","year":"1985","journal-title":"Arch Dis Child"},{"key":"2019041122545127300_R48","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1515\/JPEM.1987.2.2-3.115","article-title":"Oxandrolone therapy in boys of short stature.","volume":"2","author":"Hochberg","year":"1987","journal-title":"J Pediatr Endocrinol"},{"key":"2019041122545127300_R49","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1542\/peds.91.4.716","article-title":"Long-term results of treatment with low-dose fluoxymesterone in constitutional delay of growth and puberty and in genetic short stature.","volume":"91","author":"Strickland","year":"1993","journal-title":"Pediatrics"},{"key":"2019041122545127300_R50","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/S0022-3476(79)80170-5","article-title":"Oxandrolone therapy in patients with Turner\u2019s syndrome.","volume":"94","author":"Urban","year":"1979","journal-title":"J Pediatr"},{"key":"2019041122545127300_R51","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/BF02029351","article-title":"Treatment of patients with Ullrich-Turner syndrome with conventional doses of growth hormone and the combination with testosterone or oxandrolone: effect on growth, IGF-I and IGFBP-3 concentrations.","volume":"154","author":"Haeusler","year":"1995","journal-title":"Eur J Pediatr"},{"key":"2019041122545127300_R52","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/378681a0","article-title":"Crystal structure of the RAR-\u03b3 ligand-binding domain bound to all-trans retinoic acid.","volume":"378","author":"Renaud","year":"1995","journal-title":"Nature"},{"key":"2019041122545127300_R53","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/378690a0","article-title":"A structural role for hormone in the thyroid hormone receptor.","volume":"378","author":"Wagner","year":"1995","journal-title":"Nature"},{"key":"2019041122545127300_R54","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/39645","article-title":"Molecular basis of agonism and antagonism in the oestrogen receptor.","volume":"389","author":"Brzozowski","year":"1997","journal-title":"Nature"},{"key":"2019041122545127300_R55","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/375377a0","article-title":"Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-\u03b1.","volume":"375","author":"Bourguet","year":"1995","journal-title":"Nature"},{"key":"2019041122545127300_R56","first-page":"271","article-title":"Androgen receptor defects: historical, clinical and molecular perspectives.","volume":"16","author":"Quigley","year":"1995","journal-title":"Endocr Rev"},{"key":"2019041122545127300_R57","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1021\/bi961775g","article-title":"Functional in vivo interaction between the amino-terminal, transactivation domain and the ligand binding domain of the androgen receptor.","volume":"36","author":"Doesburg","year":"1997","journal-title":"Biochemistry"},{"key":"2019041122545127300_R58","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1210\/mend.11.8.9963","article-title":"Hinge and amino-terminal sequences contribute to solution dimerization of human progesterone receptor.","volume":"11","author":"Tetel","year":"1997","journal-title":"Mol Endocrinol"},{"key":"2019041122545127300_R59","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1006\/taap.1994.1117","article-title":"Environmental hormone disruptors: evidence that vinclozolin developmental toxicity is mediated by antiandrogenic metabolites.","volume":"126","author":"Kelce","year":"1994","journal-title":"Toxicol Appl Pharmacol"},{"key":"2019041122545127300_R60","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/338039a0","article-title":"Transcription activation by the adenovirus E1a protein.","volume":"338","author":"Lillie","year":"1989","journal-title":"Nature"},{"key":"2019041122545127300_R61","doi-asserted-by":"crossref","first-page":"4456","DOI":"10.1016\/S0021-9258(18)42855-4","article-title":"Response elements of the androgen regulated C3 gene.","volume":"267","author":"Tan","year":"1992","journal-title":"J Biol Chem"},{"key":"2019041122545127300_R62","doi-asserted-by":"crossref","first-page":"5620","DOI":"10.1016\/S0021-9258(17)33103-4","article-title":"Binding properties of androgen receptors: evidence for identical receptors in rat testis, epididymis and prostate.","volume":"251","author":"Wilson","year":"1976","journal-title":"J Biol Chem"},{"key":"2019041122545127300_R63","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/pros.2990050603","article-title":"The use of radioactive 7\u03b1, 17\u03b1-dimethyl-19-nortestosterone (mibolerone) in the assay of androgen receptors.","volume":"5","author":"Schilling","year":"1984","journal-title":"Prostate"},{"key":"2019041122545127300_R64","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0039-128X(75)80023-7","article-title":"Methyltrienolone, a specific ligand for cellular androgen receptors.","volume":"26","author":"Bonne","year":"1975","journal-title":"Steroids"},{"key":"2019041122545127300_R65","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0026-895X(25)14684-1","article-title":"Antagonistic action of anti-androgens on the formation of a specific dihydrotestosterone-receptor protein complex in rat ventral prostate.","volume":"5","author":"Fang","year":"1969","journal-title":"Mol Pharmacol"},{"key":"2019041122545127300_R66","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1210\/endo-91-2-427","article-title":"A biological profile of a nonsteroidal antiandrogen, SCH 13521 (4\u2032-nitro-3\u2032-trifluoromethylisobutyranilide).","volume":"91","author":"Neri","year":"1972","journal-title":"Endocrinology"},{"key":"2019041122545127300_R67","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1210\/endo-94-4-1205","article-title":"Action of a nonsteroidal antiandrogen, flutamide, on the receptor binding and nuclear retention of 5\u03b1-dihydrotestosterone in rat ventral prostate.","volume":"94","author":"Liao","year":"1974","journal-title":"Endocrinology"}],"container-title":["Molecular Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/mend\/article-pdf\/13\/3\/440\/10714135\/mend0440.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T11:59:43Z","timestamp":1746100783000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mend\/article\/13\/3\/440\/2741660"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,3,1]]},"references-count":67,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1999,3,1]]}},"URL":"https:\/\/doi.org\/10.1210\/mend.13.3.0255","relation":{},"ISSN":["0888-8809","1944-9917"],"issn-type":[{"value":"0888-8809","type":"print"},{"value":"1944-9917","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,3,1]]}}}